ENZY Enzymotec Ltd. - Ordinary Shares (delisted)

Enzymotec Ltd. (Nasdaq:ENZY), a developer, manufacturer and marketer of innovative bio-active lipid ingredients, today announced that the Company will release financial results for the first quarter ended March 31, 2015 on Thursday, May 7, 2015, before the market opens. Following the release, Dr. Ariel Katz, President and Chief Executive Officer, and Oren Bryan, Vice President and Chief Financial Officer will host a conference call to review the financial results.

The conference call is scheduled to begin at 8:30 a.m. ET on Thursday, May 7, 2015. Participants should dial (877) 359-9508 (United States) or (224) 357-2393 (International) with confirmation code 34316444 to access the live call. The call will also be broadcast live over the Internet, hosted in the Investors section of Enzymotec's website at http://edge.media-server.com/m/p/ac78fbrw, and will be archived online within one hour of its completion through May 14, 2015.

About Enzymotec Ltd.

Enzymotec Ltd. is a leading global supplier of specialty lipid-based products and solutions. The Company develops, manufactures and markets innovative bio-active lipid ingredients, as well as final products, based on sophisticated processes and technologies. For more information, visit www.enzymotec.com.

CONTACT: KCSA Strategic Communications
         Jeffrey Goldberger / Tram Bui
         212.896.1249 / 212.896.1290
         ENZY@kcsa.com